Medical procedures, open surgery, physical therapy, and rehabilitation have benefited from the effectiveness of technologies like VR as a supplemental tool to pharmacological pain management strategies, such as anesthesia. The present study elaborates on previously reported findings (Mosso et al., 2016) of virtual reality assisted anesthesia during upper gastrointestinal surgery of 115 patients.
An upper gastrointestinal endoscopy explores gastrointestinal (GI) organs such as the esophagus, stomach, and second portion of the duodenum [1] . A colonoscopy explores structures such as the end of ileum, cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum. In conjunction with an ileoscopy and a retrograde endoscopic cholangiography, these procedures, constitute a Gastrointestinal Endoscopy. Today, over one million GI endoscopies are performed annually, yet a shortage of specialists to perform these procedures is creating a need for more efficient and effective practices [2, 3] . As with any medical procedures, it is pertinent to maintain and control patient comfort. While approaches to this aspect of surgery vary, common practices involve anesthetics and/or pain distraction techniques. In the present study, local anesthesia was administered, enabling patients to stay more aware and responsive [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Previous studies have shown that immersive virtual reality [VR] distraction is a very useful adjunctive therapy in the management of clinical pain syndromes [19] [20] [21] [22] . Notably, Vázquez and colleagues [22] found that when immersed in virtual environments, patients' postoperative anxiety was reduced. Additionally, other studies have used distraction techniques, such as listening to music or watching movies, during procedures to decrease intraoperative anxiety and pain ratings [20, 21] .
For more than twenty years, healthcare specialists, from physicians to psychologists, have supplemented treatments and surgeries and even implemented preventative methods using VR [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] . Researchers and clinicians have applied VR as a supplementary tool to treat behavioral disorders and phobias [39, 40] , reduce anxiety [22] , and manage chronic pain in patients [25, 27, 28, [32] [33] [34] [35] [36] [37] [38] . These interventions underscore the widespread applicability of VR to serve as an adjunctive pain management tool in a variety of healthcare procedures. As such, in a precursor to this article, we examined and reported the first clinical application of VR as a somatic pain distraction technique during endoscopic procedures [41] . Focusing on subjective reports of discomfort, we found VR to significantly reduce pain during surgical procedures administered with local anesthesia [41] . While we are still seeking methods for quantifying pain levels, we have had success with non-invasive physiological monitoring.
The ability of VR to influence autonomic responses is well documented. Researchers reference these capabilities in studies addressing anxiety disorders [26] , dental pain [35] , and posttraumatic stress disorder (PTSD) [42] . Research validating the efficacy of VR to elicit both arousal and relaxation reinforces these findings [42] [43] [44] . Monitoring physiological arousal is increasingly becoming an integral feature of virtual reality therapy (VRT) for pain management (see Table  1 ). Mosso and colleagues demonstrated the link between autonomic responses to pain and patients' respective subjective ratings [37] . This study found positive correlations between physiological measurements, such as respiration rate and heart rate, and subjective Likert scale ratings of pain in patients who had recently undergone cardiac surgery. Furthermore, they concluded that immersion in VR can enhance traditional pain management strategies and aid in the reduction of stress [37] .
While VR has been implemented as a stand-alone treatment option for pain management, the ability to use it in conjunction with traditional analgesic options, such as anesthesia, offers greater flexibility. Additionally, research suggests that VR may aid in reducing the amount of medication needed for particular surgeries [36] . The present study aims to expand on these findings and explore relationships between subjective and objective measurements of pain in patients undergoing endoscopic procedures. Our initial study [41] reports patients' subjective levels of pain during endoscopic procedures. We also measured a number of important physiological parameters to see if patients had autonomic responses to VR therapy. Objective physiological measures will allow us to quantitate the effective use of VR assisted anesthesia (VRAA) for non-complicated patients in need of upper endoscopic procedures. Thus, extending our initial examinations, we explore the relationship between subjective and objective measurements of pain, the effects of VRAA on physiological measurements of pain, and assess the effectiveness of VRAA in specific procedures, age ranges, and within genders. Nonphobics (n = 22) were outfitted with a head mounted display presenting six different 3D virtual flying scenes. Aviophobics (n = 36) were first taught relaxation techniques and gradually exposed to flying scenarios. Skin resistance, skin temperature, and heart rate were measured via sensors place on the body and a Likert based anxiety scale was administered.
The intervention was effective in reducing phobics' physiological and subjective measurements of stress. VR reduced average heart rate and subjective measurements of stress, suggesting the effectiveness of VR as a technique to control fear and anxiety during dental procedures.
Effects of physiotherapy associated to virtual games in pain perception and heart rate variability in cases of low back pain. Zavarize SF, Paschoal MA, Wechsler SM.
Twenty-one (21) adults diagnosed with lower back pain were split into two groups, both receiving physical therapy, but only one supplemented treatment with virtual games.
Patients in the virtual game group exhibited greater reduction in subjective pain and heart rate variability. This authors suggests the virtual games aid in pain distraction and influence pain perception.
Virtual Reality for Pain Management in Cardiac Surgery. Vasquez JL, Gao K, Wiederhold BK, Wiederhold MD Sixty-seven patients who had recently received cardiac surgery participated. Each patient navigated through virtual world designed for pain distraction for thirty minutes. Physiological measurements included heart rate, respiration rate, and arterial pressure, while subjective pain was measured on a visual analog scale (VAS).
Results indicate positive correlations between respiration rate, heart rate, and mean arterial pressure and scores on the VAS.
METHODS

Participants
This study took place at the Endoscopy Service at the Pisanty Clinic of the ISSSTE in Mexico City. 115 outpatients participated with full informed consent. Thirty four males and eighty one females without cardiorespiratory disease participated (18 to 90 years old). The non-VR group (n=59) received local anesthesia, while the VR group (n=56) received local anesthesia and an immersive VR relaxation environment. In the non-VR group, the age range was 27 to 81 years (M = 53.2), while the treatment group ranged between 27 and 86 years of age (M =47.6). 70% were female and 30% were males.
Stimulus
The immersive virtual scenarios used were Enchanted Forest, Magic Cliff, Enchanted Castle, and Shell Island, all developed at The Virtual Reality Medical Center, La Jolla, California (Figure 1) . Each of these four environments are clinically validated pain management and relaxation worlds to reduce autonomic stress responses.
Materials
Necessary equipment for endoscopic procedures included an optic fiber to transmit the image to a monitor, a light source for illuminating the inside of the cavities and insufflation to distend the virtual spaces of organs. Additionally, instruments inserted through the endoscope were used to take samples for cytological and histological examinations (Biopsy forceps), and to cauterize, infiltrate, dissect, cut, and remove superficial injuries. Heart rate and additional sensors were used to measure each patient's vital signs. Oral gauze pads were also used to measure oral secretion.
Procedures
All patients were referred to the clinic with benign diagnoses of Peptic Ulcer Disease (PUD), Gastritis, Esophageal Reflux, upper GI bleeding, Duodenogastric Reflux, Esophageal Varix, and Human Immunodeficiency Virus (HIV) amongst others (see Table 2 ). To become accustomed to the intervention, the VR group was trained how to navigate the virtual environment prior to the procedure. We performed upper endoscopy explorations with biopsy tests. Prior to the beginning of surgery, all patients were fitted with heart rate monitors on their chest, respiration monitors around their abdomen, and gauze pads placed in their mouths. Each patient's vital signs were measured before, during, and after the procedure, as were their subjective perceptions of pain, gathered via self-report on the Visual Analog Scale (VAS). With the patient seated, initial vital signs and patient pain were recorded. All procedures were done under local anesthesia-the physician sprayed 5 to 7 shots of spray-xylocaine into the oral cavity before beginning the procedure. With the patient laying on their left side decubitus with an oral protector (nozzle), the physician set up the head mounted display (HMD) linked to a laptop in order to present one of the four virtual environments (see Figure 1) . The physician then inserted the endoscope through the oral cavity into the upper esophagus. Next, the patient was instructed to swallow in order to insert the endoscope through the esophagus. The VR headset and environment was turned on and the patient began navigation. Continuing to explore the stomach and gastric antrum, the endoscopist performed a retrovision maneuver to explore the gastric fundus and its gastric body. Because the bending of an endoscope can cause distention (air inflation) and pain, we decided that this was the optimal time to record intraoperative vital signs. This data was recorded as Heart Rate (HR) During, Respiration Rate (RR) During, and Face-or subjective, self-report pain-During. If necessary, the endoscopist took biopsy samples from the fundus, body, or gastric antrum. We continued with the exploration of the first and second portion of duodenum where vital signs were again measured. The procedure ended and the endoscope was removed. After the endoscope was extracted, gauze pads were analyzed. These oral secretion measurements served as indicators of stress levels during the procedure. Patients in the VR group continued immersion in the virtual environment for 10 minutes after the conclusion of the procedure while the endoscopist cleaned the equipment. At this time, the last vital signs, pain ratings, and gauze pad measurements were recorded.
Measures
Subjective vital signs were recorded before, during, and after the procedure via the pain Visual Analog Scale (VAS). This Likert scale instructed patients to rate pain on a scale of 0-10 (0 = no pain, 10 = maximum pain). Physician Stress was measured on a self-report scale of 1-3 (1 = no stress, 2 = some stress, and 3 = maximum stress). Objective measures of patient stress included hear rate (HR), respiration rate (RR), and oral salivation. HR and RR were both measured via sensors placed on the patient's body. To measure HR, sensors were placed on the chest, while waistband sensors were placed around the abdomen to measure RR. Gauze pad salivation was measured on a scale of 0-3. A score of zero (0) meant there was no salivation. If saliva covered one-third of the gauze, a score of one (1) was recorded. A score of two (2) was recorded if two-thirds of the gauze was covered and a score of three (3) if the gauze was completely covered in saliva or more.
Statistical Analysis
An Analysis of Variance (ANOVA) was conducted between the VR and non-VR groups. Additional ANOVA tests were run to assess physiological differences according to age, gender, and procedural type both between and within groups. Alpha was set at p ≤ .05. Cohen's d was also calculated as a measure of effect size.
RESULTS
As reported in our initial article [41] , overall pain, as measured on the VAS scale (0= no pain, 10= maximum Figure 2 ). Overall HR was not significantly different in this study, however, subgroups of patients did show reduced HR. Our next study will measure heart rate variability (HRV) as this has been shown to be a more sensitive indicator of stress and pain [44] .
There were no between gender differences on any physiological or subjective scales. However, within gender comparisons between the VR and non-VR groups suggest a strong effect of VR on salivation levels (Figure 3) . Males in the VR group produced nearly half as much saliva as males in the non-VR group (M VR = 1.38, SD VR =.973, M non-VR = 2.46, SD non-VR = .776; F (1, 32) = 11.459, p = .002, d = 1.231). Females in the VR group also secreted significantly less than their non-VR group counterparts (M VR = 1.68, SD VR =.867, M non-VR = 2.28, SD non-VR = .861, F (1, 79) = 9.503, p = .003, d = .700).
Differences in physiological and subjective measurements of pain were also assessed in relation to the four most frequent diagnoses. Patients were most often diagnosed with either a hiatal hernia (n = 54), normal (n = 22), peptic ulcer (n = 22), or reflux (n = 10). Across these four most common diagnoses, we found notable differences, presented in Table 4 . First, heart rate during hiatal hernia procedures was slightly lower in the non-VR group than in the VR group (M VR = 123.58, SD VR Comparisons of respiration rate between diagnoses also elucidated clinically significant differences suggesting patients in the VR group were more relaxed Final analyses explored age differences between the two groups. Splitting each group into three separate age ranges, 20-39, 40-59, and 60 and above (60+), these tests produced varied results ( Table 5) 
DISCUSSION
The current study indicates the effectiveness of VR as an assistive analgesic. Our preliminary study with this patient sample [41] suggested the efficacy of VRAA to lower patients' perceived pain by immersing them in clinically validated virtual reality worlds. In addition to that report, we also assessed the capability of VR to manage physiological manifestations of pain, stress, and anxiety in this paper. Statistical analyses reveal interesting results and relationships between physiological manifestations of pain and patients' selfreport levels of pain.
First, identifying significant decreases in respiration rate in the VR group suggests that patients, when immersed in virtual worlds, are relaxing more than their non-VR counterparts. Next in the comparisons between groups, we identified significantly lower oral secretion levels in the VR group. This finding supports our initial report of decreased perceived pain in the VR group, as oral secretion is traditionally measured as an autonomic indicator of pain. In addition, when assessing differences within genders, both males and females in the non-VR group secreted nearly twice as much as their VR group comparisons. We did, however, find HR to be increased in some subsets and decreased in other subsets when comparing the VR to the non-VR groups. We suspect that while heart rate can be an indicator of stress, it is rather a characteristic of increased immersion in the virtual environments. In fact, heart rate may not be as valid of a measurement for understanding pain as previously thought. Instead, as Wilhelm and colleagues [45] have implied in a study of virtual reality exposure therapy, the assessment of heart rate variability may be a more valid measure of emotional processing.
Further exploration uncovered the efficacy of VR during specific procedures. We assessed group differences across diagnoses, presented in Table 4 . These results suggest the capability of VR to reduce physiological measurements of pain including respiration rate and oral secretion and reflect the increase in heart rate found in preliminary analyses. Respiration rate decreased across the four most common diagnoses between 4% and 35%. Oral secretion exhibited the most profound differences, with the VR group secreting 45% less, on average, than the non-VR group. This measurement was the most consistent throughout the trial and suggests its validity as a predictive construct of autonomic arousal. In future studies, we will measure Heart Rate Variability (HRV), skin temperature, skin conductance, and the electroencephalogram (EEG) using a quantitative EEG (qEEG) device. Finally, our assessment of age differences shows lower respiration rate, oral secretion, and perceived pain across each age interval, while hear rate, again, maintained or slightly increased between groups.
Overall, we conclude that the ability of the VR pain management intervention to produce statistically significant lower levels of reported pain, respiration rate, and oral secretion underlines its capability as an effective tool in managing physiological responses to pain. The vast differences in oral secretion between the non-VR and VR groups is important as it highlights the relationship between arousal and pain. Additionally, time per procedure was decreased for patients in the VR group, a clinically significant outcome. Heart rate measurements during VR assisted procedures show variable results. Simple heart rate measurement is useful in a number of clinical conditions where severe pain (i.e. post-operation pain), arrhythmia, dehydration, or high sympathetic tone (as in hyperthyroidism or high metanephrine) are present. Evaluation of underlying stress and anxiety require more sensitive techniques and HRV is one example. We have also evaluated change in the electrocardiogram (not reported). Increased immersion, or psychological engagement, in turn, is more often associated with a decrease in subjective pain.
CONCLUSION
Virtual reality assisted anesthesia (VRAA) is an effective tool during endoscopic procedures in noncomplicated patients. Lowering physiological responses to pain, subjective reports of discomfort, and even reducing physician stress and time to complete the procedure indicates a valuable additional tool over traditional pain management techniques. Being the largest study on VR distraction and endoscopic procedures, this study suggests important new constructs and techniques for pain management during upper gastrointestinal procedures. This is the first large series of patients undergoing GI endoscopic procedures and VRT. The VR procedure is flexible and can be adapted to the operating room or the bedside. Whether VR can effectively replace anesthesia is an interesting question to contemplate. Due to the success of this study, however, it may be appropriate to assess the effectiveness of VR in similar procedures, such as colonoscopies.
It is important that subsequent research continues to explore and identify more effective pain management techniques using advanced technologies. As suggested earlier, simple heart rate may not be an appropriate indicator of patient pain. There are many advanced digital analysis techniques that are under investigation for analyzing cardiovascular responses to stress anxiety on pain. We will continue to explore these approaches in our medical and invasive procedures and surgical interventions. Overall, this study provides additional clinical validation for the effective use of virtual reality during upper gastrointestinal endoscopy procedures for diagnosis in non-complicated patients. The ability to manage procedural pain and stress has obvious positive effects and clinical outcomes.
